Compare Biocon with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON AJANTA PHARMA BIOCON /
AJANTA PHARMA
 
P/E (TTM) x 42.7 27.2 157.2% View Chart
P/BV x 5.8 6.4 90.0% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 BIOCON    AJANTA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-21
AJANTA PHARMA
Mar-21
BIOCON /
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4881,883 25.9%   
Low Rs2751,258 21.8%   
Sales per share (Unadj.) Rs59.2334.0 17.7%  
Earnings per share (Unadj.) Rs7.775.6 10.2%  
Cash flow per share (Unadj.) Rs13.789.0 15.4%  
Dividends per share (Unadj.) Rs09.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs62.3346.1 18.0%  
Shares outstanding (eoy) m1,200.0086.53 1,386.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.44.7 136.9%   
Avg P/E ratio x49.420.8 237.8%  
P/CF ratio (eoy) x27.917.7 158.0%  
Price / Book Value ratio x6.14.5 134.9%  
Dividend payout %012.6 0.0%   
Avg Mkt Cap Rs m457,350135,898 336.5%   
No. of employees `000NANA-   
Total wages/salary Rs m17,4105,483 317.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m71,05828,897 245.9%  
Other income Rs m6,052260 2,329.5%   
Total revenues Rs m77,11029,157 264.5%   
Gross profit Rs m13,1459,986 131.6%  
Depreciation Rs m7,1511,161 616.0%   
Interest Rs m57783 697.7%   
Profit before tax Rs m11,4699,002 127.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2152,463 89.9%   
Profit after tax Rs m9,2546,539 141.5%  
Gross profit margin %18.534.6 53.5%  
Effective tax rate %19.327.4 70.6%   
Net profit margin %13.022.6 57.6%  
BALANCE SHEET DATA
Current assets Rs m76,00422,178 342.7%   
Current liabilities Rs m42,1018,388 501.9%   
Net working cap to sales %47.747.7 100.0%  
Current ratio x1.82.6 68.3%  
Inventory Days Days13753 258.9%  
Debtors Days Days639 670.6%  
Net fixed assets Rs m106,14218,912 561.2%   
Share capital Rs m6,000174 3,450.3%   
"Free" reserves Rs m68,72829,777 230.8%   
Net worth Rs m74,72829,951 249.5%   
Long term debt Rs m29,61616 185,100.0%   
Total assets Rs m182,14641,090 443.3%  
Interest coverage x20.9109.8 19.0%   
Debt to equity ratio x0.40 74,187.9%  
Sales to assets ratio x0.40.7 55.5%   
Return on assets %5.416.1 33.5%  
Return on equity %12.421.8 56.7%  
Return on capital %11.530.3 38.1%  
Exports to sales %00-   
Imports to sales %7.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m5,084NA-   
Fx inflow Rs m11,79118,097 65.2%   
Fx outflow Rs m5,0842,315 219.7%   
Net fx Rs m6,70715,782 42.5%   
CASH FLOW
From Operations Rs m11,5975,763 201.2%  
From Investments Rs m-36,247-2,824 1,283.6%  
From Financial Activity Rs m25,640-3,183 -805.6%  
Net Cashflow Rs m723-244 -296.7%  

Share Holding

Indian Promoters % 39.7 70.3 56.5%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 23.4 21.5 108.5%  
FIIs % 16.0 9.0 178.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 29.7 132.7%  
Shareholders   364,502 57,897 629.6%  
Pledged promoter(s) holding % 0.0 15.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Sheds 581 Points, Nifty Ends Near 17,100; HCL Tech & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

BIOCON Announces Quarterly Results (2QFY22); Net Profit Up 4.9% (Quarterly Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

For the quarter ended September 2021, BIOCON has posted a net profit of Rs 2 bn (up 4.9% YoY). Sales on the other hand came in at Rs 18 bn (up 5.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of BIOCON for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BIOCON . Also includes updates on the valuation of BIOCON .

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jan 27, 2022 03:36 PM

TRACK BIOCON

BIOCON - NORRIS MEDICINES COMPARISON

COMPARE BIOCON WITH

MARKET STATS